Another company’s lung fibrosis study has failed, on safety concerns. I can’t access the whole article because it is behind a paywall on Feuerstein’s site, but the headline says all we need to know:

Quote:

---

Pliant pauses Phase 2b lung fibrosis study after safety board recommendation

---